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Understanding how people respond to information about treatment options is imperative for 
informing efforts to promote treatment initiation and adherence. The present study examines the 
impact of informational treatment videos on treatment naive participants’ views of treatment 
credibility, expectations, and prognostic pessimism. U.S. adults (N = 300) with elevated 
depressive symptoms and no history of treatment for depression were randomly assigned to one 
of four conditions: (1) a video with information about cognitive behavioral therapy (CBT); (2) a 
video with information about antidepressant medication (ADM); (3) a video with information 
about the combination of ADM and CBT; and (4) a control group not shown a video. Primary 
outcome variables included participants’ self-reported credibility, expectations, and prognostic 
pessimism measured before and after watching any video to which they were assigned. 
Compared to the control condition, videos describing either single treatment alone enhanced 
expectations and credibility for that treatment (with the exception of ADM expectations, which 
did not differ significantly). Those shown the CBT only video reported the most positive 
expectations and highest credibility for CBT. Those shown the ADM only video reported the 
most positive expectations and credibility for ADM. Those who viewed the combined treatment 
video did not differ from other conditions on any of the dependent variables (with the exception 
of a significant difference between CBT and combination conditions for expectations of CBT). 
There were no condition differences in prognostic pessimism. Future research could use 
informational videos to investigate the effects of other kinds of messaging on the variables 
examined in this study, as well as treatment seeking, adherence, and treatment outcomes.   
Keywords: depression, treatment options, expectations, credibility, prognostic pessimism, 
preference, personalization 
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Impact of Treatment Information on Views of Treatment Options for Adults with 
Depression 
 Major depressive disorder, known commonly as depression, is one of the most common 
mental disorders, affecting hundreds of millions of people around the world (GBD 2017 Disease 
and Injury Incidence and Prevalence Collaborators, 2018). It is estimated that 17.7 million U.S. 
adults had experienced at least one episode of depression in 2018 (Substance Abuse and Mental 
Health Services Administration, 2019). Depression often varies in severity, but it universally 
results in personal distress and an impairment of functioning. Common symptoms associated 
with depression are low mood, loss of interest, and suicidal thoughts or actions, contributing to 
depression being a leading cause of disability and death by suicide (American Psychiatric 
Organization, 2013; GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, 
2018). Given the considerable functional impairment associated with depression, a large focus of 
mental health research is devoted to understanding the disorder in order to improve treatment 
options and their implementation.  
 Depression is often explained through two levels of analysis: a biological level and a 
psychological level. The biological level of analysis emphasizes the effect that biological factors 
such as genetics and brain chemistry have on mental health (Lebowitz & Appelbaum, 2019). A 
simple understanding of this level is that variation in the regulation of chemicals in the brain may 
give rise to symptoms, and the use of antidepressant medication (ADM) may improve symptoms 
by regulating these chemicals. However, it is important to recognize that the biological 
underpinnings of depression have yet to be fully elucidated. Although often used in drug 
marketing campaigns, an understanding of depression as simply caused by the abnormal levels of 
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key neurotransmitters (as suggested by the monoamine hypothesis) does not reflect the current 
state of the evidence (Liu et al., 2017).  
Another important level of analysis is the psychological level, which instead emphasizes 
factors such as cognition, behavior, and social interactions (Lebowitz & Appelbaum, 2019). 
Consistent with this level, cognitive behavioral therapy (CBT) is often used to help teach patients 
skills to address the overly negative thoughts and maladaptive behaviors associated with 
depression. The psychological level of analysis is important for recognizing how negative 
thought patterns and self-destructive behavior are often associated with and can contribute to 
depression. Despite this, this level of analysis tends to de-emphasize the role of neurobiology and 
genetics in depression, both important factors that are important for understanding depression in 
its entirety.  
 It is important to recognize that these levels of analysis are not mutually exclusive. 
Depression can be understood through both levels of analysis. The importance of both levels 
might lead one to expect a combination of CBT and ADM could be used to treat depression most 
effectively. This approach of viewing depression through multiple levels of analysis may be 
becoming more popular among researchers, as part of an effort to better appreciate the variations 
and complexities of this disorder (Belmaker & Agam, 2008). Considerable research has 
examined the relative effectiveness of depression treatments, and the available evidence shows 
that CBT and ADM are approximately equally effective as acute treatments for depression (Mor 
& Haran, 2009). However, it is ultimately up to patients to make informed decisions about which 
treatment or treatments are most appropriate for them. The ability to choose a treatment option is 
often viewed as important for respecting patients’ autonomy, but it also makes it clear that how 
patients process information about treatment options is important to understand. This study 
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examined how people respond to information about depression treatments as part of an effort to 
identify effective ways of promoting treatment seeking, adherence, and positive outcomes.  
Choosing a treatment option can be a difficult process, perhaps especially for those who 
have not had prior experience with depression or other mental illnesses. Treatment naive 
patients, or people who have never been treated for depression, often consult their primary 
physicians as a primary source of information on treatment options (Simon et al., 2006). Primary 
care physicians provide key information about treatment options. However, over the past few 
decades, the American healthcare system has arguably shifted toward a more biological approach 
to mental health, with less attention being paid to psychological and social factors (Deacon, 
2013). Physicians understandably emphasize the biological factors and biological treatments for 
depression, but it is unclear how this effects patients’ views of other options. In addition, 
information about these treatments may come from other people or various advertising 
campaigns, which may not be entirely accurate or include even the most critical information 
about treatment options. Thus, it is imperative to understand how such messages affect people’s 
views of depression and depression treatment options. Understanding how patients learn about 
and decide on a course of action regarding treatment is key to helping to ensure that patients can 
make informed decisions that are likely to be beneficial for them. To help achieve this, this study 
was designed to examine how U.S. adults responded to information about CBT, ADM, and 
combination treatment. Responsiveness to messaging has been studied in a few different ways, 
but some of the key variables that might be influenced by messaging are expectations and 
credibility regarding specific treatment options.  
 Expectations and credibility both play a significant role in the therapeutic effects of many 
interventions. Many studies have found that patient expectations predict treatment outcome for 
IMPACT OF TREATMENT INFORMATION 
 
6 
both physical and psychological illnesses, and further research has attempted to determine what 
can change expectations and whether such changes improve the effectiveness of treatment 
(Constantino, Ametrano, & Greenberg, 2012; Goldfarb, 2011; Laferton et al., 2017; Vîslă et al., 
2016; Younger et al., 2012). Having positive expectations and viewing a treatment as highly 
credible predicts a greater willingness to seek it out and may even potentially improve treatment 
outcomes (Constantino et al., 2012). These findings show that expectations and credibility are 
key variables to assess in considering how people respond to treatment information. In the 
context of this study, I examined changes in attitudes following messaging by assessing 
perceptions of the treatments’ credibility and expectations for outcome with the treatment. 
Evidence from previous research highlighting the predictive validity of credibility and 
expectations in predicting treatment engagement and outcomes was a core reason for selecting 
these variables as primary dependent variables in this study.   
 Another potentially important factor that could be impacted by treatment messaging is 
prognostic pessimism. Prognostic pessimism is the idea that mental illnesses are permanent, and 
that treatment is unlikely to effectively treat the disorder. Prognostic pessimism has been studied 
in research focused on the possible consequences of believing different etiological explanations 
for depression. Kemp and colleagues (2014) used an experimental design to test the effect of a 
biological explanation for depression on prognostic pessimism. The researchers had participants 
who reported a current or past depressive episode complete a bogus test that supposedly 
measured the levels of different chemicals in the brain. The results of this test were either given 
back in a way that suggested their symptoms were or were not caused by a chemical imbalance 
in the brain. Compared to the control condition, feedback that supported the biological 
explanation worsened prognostic pessimism. In addition, receiving the biological explanation for 
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depression increased the credibility and expectations of pharmacological treatment compared to 
psychosocial treatment (Kemp et al., 2014).  
 In another relevant study, Lee and colleagues (2016) used video-based messaging to 
explore the impact of etiological explanation on self-stigmatizing attitudes. This study used a 
video-based messaging strategy similar to that of the present study, randomly assigning 
participants to view a short and accessible video describing their depressive symptoms being due 
to biological factors, cognitive behavioral factors, or their combination. However, my research 
questions differed in some important ways. Whereas the previous study focused on explanations 
for depression, I focused on providing information about the treatment itself. This allowed me to 
evaluate messages that likely more closely parallel the kind of messaging that is provided when 
treatment options are described in a clinical context. 
 When people receive information about depression treatments, the messages are most 
often delivered to prospective patients without regard for their initial views or preferences. The 
advertisement for a new antidepressant or a recommendation that a treatment naive person 
receives is likely not based on their initial preference, and we know little about how this affects 
those receiving the message. Patients do typically have an initial preference for a treatment, and 
there is evidence that receiving treatment based on preference significantly improves initiation 
and treatment outcome (Kwan, Dimidjian, & Rizvi, 2010; Lin et al., 2005; Raue et al., 2009). 
While previous work has focused on the role of preference in treatment outcomes, research has 
yet to focus more specifically on how the effects of receiving messaging that aligns with 
preferences differs from the effects of messaging that contradicts them. This study aims to 
address this gap in understanding by determining whether personalizing messaging to one’s 
initial preference improves responsiveness to the message.  
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 The present study was also designed to address how emphasizing the personalization of 
treatment affects credibility, expectations, and prognostic pessimism. Treatment options are not 
universally applied to every patient, as mental health professions will often work with their 
patients to devise a treatment strategy tailored to the patient and their needs. I believe that it is 
important to examine the effects of emphasizing how each treatment option can be personalized 
compared to the effects of not providing such an emphasis.  
 The emphasis on preference, personalization, and information about treatment options 
themselves clearly distinguishes this study from previous research. Thus, this study builds on 
previous work in an effort to improve our understanding of how treatment naive patients with 
depression respond to information on different treatments. By better understanding the 
consequences of different messaging, we may be able to start to address the estimated 35.2% of 
adults suffering from depression who do not receive treatment (Substance Abuse and Mental 
Health Services Administration, 2019), and improve the way that we provide information about 
treatment to those who need it.   
Study Objectives 
 This study examined how people respond to messages about CBT, ADM, and 
combination treatment. Participants were randomly assigned to watch a brief (2-minute) video 
with information about the rationale, experience of participating in, and benefits of one of these 
treatment options, while a control group received no video. In addition, participants assigned to a 
video were also randomly assigned to receive a version of the video that did or did not include 
and emphasis on how that treatment can be personalized (for a total of seven conditions). The 
objectives of this study are: (1) to examine the impact of providing information on depression 
treatment options on participants’ views (i.e. credibility, expectations, and prognostic 
IMPACT OF TREATMENT INFORMATION 
 
9 
pessimism); (2) to determine the benefits of receiving information that does or does not fit with 
one’s initial preference; (3) to test the effects of emphasizing treatment personalization when 
providing information about treatment options; and (4) to assess whether the impact of treatment 
messaging on credibility and expectations is moderated by stigma or beliefs about the etiology of 
depression.  
First, I hypothesized that participants who viewed a video about a treatment option will 
report higher credibility and expectations for that treatment option as compared to the control 
condition. Second, I also hypothesized that all participants who watch a video will report lower 
prognostic pessimism than control. Third, I predicted that initial treatment preference will 
moderate response to the videos such that those who view a video about a treatment they prefer 
will experience greater increases in expectancy and credibility than those who do not prefer the 
treatment they viewed. Fourth, I also predicted that videos that included an emphasis on 
treatment personalization would lead to greater improvements in participants’ expectations and 
credibility of each treatment option as compared to videos without that emphasis. Fifth, I 
expected that personal stigma will moderate response to the videos such that the superiority of 
the CBT condition over control for credibility and expectations of CBT will be highest for 
participants who reported high personal stigma. Finally, I expected that biological beliefs about 
the etiology of depression will moderate response to the videos such that the superiority of the 
ADM condition over control for the credibility and expectations of ADM will be highest for 
participants who reported high biological beliefs about the etiology of depression.   
Methods 
Participants 
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 Participants (N=300) were recruited through a Human Intelligence Task (HIT) on 
Amazon Mechanical Turk (MTurk) via the online software program CloudResearch. MTurk 
Workers who are 18 or older and have an MTurk HIT approval rating of 95% or higher 
completed a brief prescreening to determine eligibility. In addition, I instituted a CloudResearch 
recommended feature to improve data quality by blocking low quality participants who had 
failed previous attention checks or used suspicious IP addresses. Inclusion criteria were: 18 years 
of age or older, current U.S. resident, 95% HIT approval rating or higher, evidence of a likely 
prior experience of depression as indicated by a score of 10 or higher on a version of the Patient 
Health Questionnaire-9 modified to assess a two-week period when one experienced the highest 
level of depressive symptoms (PHQ-9; Kroenke, Spitzer, & Williams, 2001), and reporting no 
prior treatment for depression.  
The inclusion criteria were relaxed during the study to facilitate recruitment. Initially, a 
score of 10 or higher on the original version of the PHQ-9 was required. This requirement was in 
place for the first 125 participants. The criteria were relaxed to require a score of 10 or higher on 
the historical version of the PHQ-9, which was in effect for the remaining 175 participants. The 
historical version of the PHQ-9 assessed depressive symptoms during a two-week period when 
one experienced the highest level of depressive symptoms rather than only in the past two weeks, 
as the original version of the PHQ-9 did. The final 175 participants completed both the historical 
and original version of the PHQ-9.  
Once study eligibility had been determined, participants who signed an informed consent 
document were allowed entry into the study. Participants who incorrectly answered attention 
check questions included in the questionnaires were also excluded from the study. Participants 
were randomized to receive a type of informational video on a specific depression treatment 
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option (with and without and emphasis on personalization) or a control group involving no 
video.   
Measurement / Instrumentation 
Prescreening Measures (Pre-Informed Consent) 
 History of Treatment. Using a single item, participants reported if they had ever taken 
any medication or participated in a therapy for depression. Participants had to indicate no prior 
treatments to be eligible to participate.  
Patient Health Questionnaire-9 historical version. The PHQ-9 is a brief 9-item self-
report questionnaire used in screening for study eligibility. The PHQ-9 was altered to include an 
assessment of the history of depressive symptoms rather than depressive symptoms within the 
last 2 weeks. This version of the PHQ-9 asked participants to identify a 2-week period during 
their lifetime when their depressive symptoms have been most severe and asked: “For the 
questions that follow, please indicate how often during that 2-week period you were bothered by 
the following problems.” Participants responded on a scale of 0-3 with each value designated as 
follows: 0-not at all, 1-several days, 2-more than half the days, 3-nearly every day. 125 
participants only received the original PHQ-9 for screening purposes, but during data collection I 
decided to adjust inclusion criteria to include previous depressive episodes in order to improve 
the rate of recruitment. After this adjustment, the remaining 175 participants received both the 
historical and original PHQ-9.  
 Treatment Preference/Willingness to Seek Treatment. Participants were asked about 
their treatment preference (with the option to select either CBT, ADM, or combination 
treatment) and their willingness to seek treatment for each option using a 5-point Likert scale.  
Study Measures (Post-Informed Consent)  
IMPACT OF TREATMENT INFORMATION 
 
12 
Beliefs about the Etiology of Depression. Personal beliefs about depression etiology 
were measured using the modified Reasons for Depression Questionnaire (RFD; Addis, Truax, & 
Jacobson, 1995; Leykin, DeRubeis, Shelton, & Amsterdam, 2007). The modified version was 
shortened in order to include only especially prevalent beliefs regarding the etiology of 
depression (Leykin et al., 2007). The RFD is a 14-item scale presenting participants with reasons 
why they may be depressed. It is scored on a 0-3 Likert scale with options ranging from a 0 for 
“definitely not a reason” to a 3 for “definitely a reason.” Leykin et al., reported the following 
Cronbach’s alphas for the subscales: “Characterological subscale (3 items) = .46, Biological (3 
items) = .65, Intimacy (2 items) = .63, Childhood (2 items) = .86, Relationship (3 items) = .91” 
(Leykin et al., 2007). An example of the childhood subscale is the item: “I am depressed because 
of certain things that happened to me as a child.” A high childhood score would mean that the 
participant believes their depression is due to childhood experiences. The RFD was presented to 
participants both before and after experimental manipulation.  
 Credibility and Expectations for Treatment. The Credibility/Expectancy 
Questionnaire (CEQ; Borkovec & Nau, 1972) was used as a primary outcome measure to assess 
expectations of treatment and its perceived credibility. Evidence supports the reliability and 
validity of the CEQ. Estimates of Cronbach’s alpha have been of 0.90 for the expectations 
portion of the measure and 0.85 for the credibility portion (Devilly & Borkovec, 2000). The CEQ 
contains two sets of items, the first three items assessing credibility, and the final three items 
assessing expectations. Participants respond to questions about their thoughts and feelings about 
a treatment option and its likely success. All three items assessing credibility are scored on a 0-9 
Likert scale with options ranging from a 0 for “not at all” to a 3 for “very.” Two of the three 
items for expectations ask about how much improvement in functioning is expected and are 
IMPACT OF TREATMENT INFORMATION 
 
13 
scored on a scale from 0% to 100%. The final item is scored using the same Likert scale as the 
items assessing credibility. Each participant responded to the CEQ for cognitive behavioral 
therapy, antidepressant medication, and combination treatment both before and after 
experimental manipulation. 
 Depression Stigma. Stigma was measured by the Depression Stigma Scale (DSS; 
Griffiths et al., 2004). The DSS includes two subscales: Personal Stigma and Perceived Stigma. 
Each subscale contains the same nine items and either ask participants how strongly they 
personally agree or how strongly they think most other people agree with each item. According 
to the Australian National University website, the DSS has continuously shown high internal 
consistency, with three separate samples showing Cronbach’s alphas of 0.77, 0.82, and 0.75 for 
the Personal Stigma Subscale, and alpha values of 0.82, 0.77, and 0.75 for the Perceived Stigma 
Subscale (Australian National University Centre for Mental Health Research, n.d.). The two 
subscales also show evidence of discriminant validity, with the correlation between the Personal 
and Perceived Stigma Subscales being .12 (Australian National University Centre for Mental 
Health Research, n.d.). The DSS was presented to participants before and after experimental 
manipulation.   
 Patient Characteristics. I included demographic questions including age, sex assigned at 
birth, current gender identity, race, and total gross yearly household income before taxes.  
Prognostic Pessimism. The other primary outcome measure was a 13-item scale 
assessing general prognostic pessimism, the Perceptions of Depression Scale (PDS; Deacon & 
Baird, 2009). The PDS consists of items assessing the perceptions of personal responsibility, 
permanence, and the effects of treatment on depression in order to assess general prognostic 
pessimism. The scale is scored on a 0-4 Likert scale with options ranging from a 0 for “not at all” 
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to a 4 for “extremely.” A previous study found Cronbach’s alpha coefficients of .73 and .68 for 
the scale in separate analyses (Deacon & Baird, 2009). The PDS was presented to participants 
before and after experimental manipulation.   
Experimental Manipulation 
 The independent variable in this study was the type of informational video provided to 
the participants. There were seven conditions that represent messages addressing three treatment 
options (CBT, ADM, and combination treatment, each presented either with or without a 
message about how these treatments can be personalized and a control condition involving no 
video). These brief (2 min) videos were designed to briefly explain what the treatment option 
involves while highlighting the rational for and benefits of the treatment. None of the videos 
described the other treatment options in any way. Each video was designed to follow the same 
structure as well as being equally factual and persuasive. Still images were placed in the 
background of each slide of the video, making sure that each video had almost exactly the same 
number of images of people, bullet points, and references to research.  
Preface 
Each video began with a preface stating “Depression is a common mental health problem. 
In this brief video, you will learn about one evidence-based treatment for depression, known as 
[treatment option].” The combination treatment video replaced “one evidence-based treatment 
for depression” with “a combination of evidence-based treatments for depression, known as 
cognitive behavioral therapy and antidepressant medication.” 
CBT Video 
The CBT video first explains that CBT is based on a cognitive behavioral model of 
depression, and that research has shown that a pessimistic outlook and stressful life events may 
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increase one’s risk for depression. A brief description of the experience of working with a 
therapist follows, noting that this work involves efforts to develop coping skills and learning to 
apply them on one’s own. The video concludes with a statement that not all therapists can 
provide CBT, while also explaining how CBT can provide symptom relief that can last for many 
years after treatment.  
ADM Video 
The ADM video begins with a simple explanation of how research has shown that 
depression may be associated with a dysregulation of chemical messengers (neurotransmitters) in 
the brain. This is different from the approach discussed in the introduction, as the video describes 
an association rather than a claim that depression is simply a result of chemical imbalances. Then 
the general function of Selective Serotonin Reuptake Inhibitors (SSRIs) are explained, noting 
that they can be effective, accessible, and easy to use. Finally, I describe some common side 
effects, noting that one can work with a doctor to manage them effectively, and that the 
continued use of ADM can provide symptom relief for many years after seeking treatment. 
Combination Treatment Video 
The combination treatment video begins with a quick explanation of the rationale for 
CBT and ADM, using the same language as above. After this, the video notes that many factors 
can contribute to depression, and state how some research has shown that the use of both may 
bring about faster relief of symptoms than CBT or ADM alone. The end of the video describes 
how combination treatment does require a larger commitment of time and money than individual 
treatment, while also having the side effects of medication, but that treatment can provide 
symptom relief for many years after seeking treatment. 
Emphasis on Personalization  
IMPACT OF TREATMENT INFORMATION 
 
16 
Participants who received a version of a video with an emphasis on personalization were 
told how within each treatment option, they could work with a health care provider to help 
determine what strategies and options will work the best for them personally.  
Procedure 
 Participants received a HIT through MTurk that contained basic information about the 
study. The HIT provided them access to a Qualtrics survey. Prior to entry, participants responded 
to screening measures. If eligible, they will be provided an informed consent document to sign. 
Upon signing the informed consent document, participants completed the study questionnaires 
mentioned in the measurement/instrumentation section above. Participants were then randomized 
to receive an experimental task, either a CBT video, an ADM video, or a video about combined 
treatment with and without an emphasis on personalization. A control group received no video, 
for a total of seven conditions. 75 participants received the CBT video, ADM video, combination 
treatment video, and control video each, with either 37 or 38 participants in each group randomly 
receiving an emphasis on personalization (with the exception of control, as all 75 received no 
video). After reviewing any videos, participants responded to another set of questionnaires. 
Participants received a $1.00 incentive as a payment through MTurk.  
Analytic Strategy 
 The data were analyzed using general linear modeling to test for the effect of treatment 
on credibility and expectations related to each treatment option (CBT, ADM, and combination 
treatment) as well as general prognostic pessimism. In order to achieve this, seven models were 
run, one for each of the dependent variables by treatment condition, controlling for the pre-
manipulation level of that same variable. The seven models examined the following dependent 
variables: credibility of CBT, expectations of CBT, credibility of ADM, expectations of ADM, 
IMPACT OF TREATMENT INFORMATION 
 
17 
credibility of combination treatment, expectations of combination treatment, and general 
prognostic pessimism. Covariates for these models included the four main levels of condition 
(CBT video, ADM video, combination video, and control) as well as the baseline scores for each 
dependent variable.  
 In addition to overall tests involving condition, I used follow-up tests to evaluate 
differences between each condition. For between group comparisons, Hedges’ g is provided as a 
measure of effect size. For follow-up analyses of an overall significant effect of condition, 
Tukey’s Honest Significant Difference (HSD) was used to adjust for the multiple tests involved. 
Additional testing included running models to examine whether participants differed across 
conditions prior to randomization and paired t-tests testing for differences pre- and post- 
experimental manipulation within the same dependent variable.   
For analysis of the potential moderators of condition differences in the dependent 
variables, the seven dependent variables described above were assessed with the secondary 
measure subscales as potential moderators. For example, there were seven models run, one 
assessing each dependent variable (credibility of CBT, expectations of CBT, credibility of ADM, 
expectations of ADM, credibility of combination therapy, expectations of combination therapy, 
and prognostic pessimism) with perceived and personal stigma (subscales of the DSS) tested as 
potential moderators of the condition differences for each dependent variable. This same process 
was repeated for beliefs on the etiology of depression with subscales of the RFD. To examine the 
effect of personalization on the dependent variables, I tested for condition differences between 
participants who received personalization and those who did not. In these analyses, the control 
condition was removed as they did not receive a video and thus never received an emphasis on 
personalization. Finally, I tested for the moderation effect of preference to examine whether 
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receiving a video that matched with one’s initial preference enhanced the condition differences 
between groups. Due to the novelty of these secondary research questions and in light of the 
number of tests being conducted, these tests are considered exploratory.  
Results 
Demographics / Participant Characteristics 
 Prior to performing statistical analyses, I characterized participant demographics and 
relevant characteristics with descriptive statistics. An overview of these descriptive statistics is 
presented in Table 1. Participants were aged 19-72 and the majority self-identified as White (n = 
234, 78.26%), with Female sex assigned at birth (n = 174, 59.59%), Female gender identity (n = 
173, 59.25%), and income below $60,000 (n = 172, 58.90%).  
The mean PHQ-9 history score was 16.99 (SD ± 4.79). The mean PHQ-9 score 
(reflecting current symptoms) was 16.34 (SD ± 4.78). The most common treatment preference 
was for CBT (n = 143, 47.67%), followed by combination treatment (n = 111, 37.00%), and then 
ADM (n = 46, 15.33%). Following randomization, the vast majority of participants did not 
receive a video describing treatment option that they preferred (n = 228, 76.00%). Participant 
frequencies for preference and match/mismatch are shown in Table 2.  
Primary Outcomes 
 The primary dependent variables of interest in this study were credibility and 
expectations of different treatment options, as well as general prognostic pessimism. Using 
regression, I first tested the effect of experimental manipulation on treatment credibility and 
expectations for the four main conditions of CBT video, ADM video, combination treatment 
video, and control. Credibility and expectations were measured separately for each treatment 
option (CBT, ADM, and combination treatment).  
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Baseline and Post Experimental Manipulation Differences 
In the model of credibility of CBT, participants did not differ in credibility of CBT across 
conditions prior to experimental manipulation (F(4,295) = 1.10, p = 0.3492), and scores in the 
CBT condition were significantly higher post experimental manipulation (t(74) = 3.38, p = 
0.0011, g = 0.39). In the model of expectations of CBT, participants did not differ in 
expectations of CBT across conditions prior to experimental manipulation (F(3,290) = 0.72, p = 
0.5396), and scores in the CBT condition were significantly higher post experimental 
manipulation (t(71) = 4.30, p < 0.0001, g = 0.51). 
In the model of credibility of ADM, participants did not differ in credibility of ADM 
across conditions prior to experimental manipulation (F(3,296) = 0.13, p = 0.9433), and scores in 
the ADM condition were significantly higher post experimental manipulation (t(74) = 3.81, p = 
0.0003, g = 0.44). In the model of expectations of ADM, participants did not differ in 
expectations of ADM across conditions prior to experimental manipulation (F(3,292) = 0.92, p = 
0.4332), and scores in the ADM condition were significantly higher post experimental 
manipulation (t(73) = 4.70, p < 0.0001, g = 0.55). 
Participants did not differ in credibility or expectations of combination treatment across 
conditions prior to experimental manipulation (credibility: F(3,296) = 0.39, p = 0.7579; 
expectations: F(3,292) = 0.19, p = 0.9019), and scores in the combination treatment condition 
were not significantly higher post experimental manipulation for either model (credibility: t(74) 
= 0.93, p = 0.3545, g = 0.11; expectations: t(72) = 1.50, p = 0.1377, g = 0.18). 
Credibility and Expectations of CBT 
In the model of credibility of CBT, there was evidence of significant differences by 
condition (F(4,295) = 4.39, p = 0.0050). Significant differences between specific conditions as 
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identified by Tukey’s HSD are shown in Figure 1. Those assigned the CBT video reported higher 
credibility of CBT when compared to control (g = 0.55), and ADM conditions (g = 0.47). The 
CBT condition was not significantly different from the combination treatment condition, but 
further analysis determined that the credibility of CBT reported by those in the combination 
treatment condition was numerically closer to the ADM (g = 0.09) than the CBT condition (g = 
0.38).  
 In the model of expectations of CBT, there was also evidence of significant differences 
by condition (F(4,286) = 5.67, p = 0.0009). Significant differences between specific conditions 
as identified by Tukey’s HSD are shown in Figure 2. The pattern of means was similar to that 
observed for credibility, but there were some differences in the specific comparisons that were 
significant. Similar to what was found for credibility of CBT, contrasts showed that those 
assigned the CBT video reported higher expectations of CBT compared to control (g = 0.64) and 
ADM (g = 0.50). Unlike what was found for credibility of CBT, those assigned the CBT video 
reported higher expectations of CBT compared to the combination treatment condition (g = 
0.39). As with credibility of CBT, the combination treatment condition was closer to the ADM 
condition (g = 0.11) than the CBT condition (g = 0.39).  
Credibility and Expectations of ADM 
In the model of credibility of ADM, there was evidence of significant differences by 
condition (F(4,295) = 6.03, p = 0.0005). Significant differences between specific conditions as 
identified by Tukey’s HSD are shown in in Figure 3. Participants in the ADM condition reported 
higher credibility of ADM than control (g = 0.54) and CBT conditions (g = 0.59). The 
combination treatment condition was not significantly different from any other condition, but it 
was closer to the ADM condition than any other (g = 0.21).  
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In the model of expectations of ADM, there was also evidence of significant differences 
by condition (F(4,289) = 4.12, p = 0.0069). Significant differences between specific conditions 
as identified by Tukey’s HSD are shown in Figure 4. Those assigned the ADM video reported 
higher expectations of ADM when compared to the CBT conditions (g = 0.56). The ADM 
condition was not significantly higher than any other condition, but it was closer to the 
combination treatment condition (g = 0.32) than the control condition (g = 0.38).  
Credibility and Expectations of Combination Treatment 
Condition differences in the credibility of combination treatment were not statistically 
significant (F(4,295) = 1.08, p = 0.3575). Similarly, condition differences in expectations of 
combination treatment were also non-significant (F(4,289) = 2.07, p = 0.1047).  
Prognostic Pessimism 
 Analysis of the model showed that there was no difference across conditions for 
prognostic pessimism (F(4,295) = 0.86, p = 0.4623).  
Exploration of Potential Moderators of Condition Differences 
 Next, I tested potential moderators of condition differences in dependent variables. These 
analyses examined depression stigma and beliefs about the etiology of depression as potential 
moderators of condition differences on the primary dependent variables.  
Personal and Perceived Stigma 
I tested seven models to examine personal stigma and perceived stigma as potential 
moderators on the effect of condition on the seven outcome variables. There was a significant 
moderation effect of personal stigma on the effect of condition on credibility of ADM. 
Examination of this effect suggested that it was driven most strongly by differential effects of 
ADM and control on ADM credibility as function of personal stigma. To illustrate this aspect of 
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the model, I used a more focused model of just ADM and control conditions to generate Figure 
5. There was a similar significant moderation effect of personal stigma on the effect of condition 
on expectations of ADM. Examination of this effect suggests that it was also driven most 
strongly by differential effects of ADM and control on ADM credibility as function of personal 
stigma. A more focused model of ADM and control conditions was used to illustrate this effect 
(see Figure 6). Both figures show that stigma appeared to attenuate the effect of the ADM video 
on ADM credibility and expectations, such that the video had a smaller effect than the control 
condition at higher levels of stigma.  
Beliefs about the Etiology of Depression 
Out of the seven models run testing the subscales of the RFD as potential moderators on 
the effect of condition on the seven outcome variables, there was only one significant interaction 
identified. Endorsing childhood etiological factors for depression moderated the effect of 
condition on the credibility of combined treatment. Examination of this effect suggested that it 
was driven most strongly by differential effects of combination treatment and control conditions. 
To illustrate this aspect of the model, I used a more focused model of just combination treatment 
and control conditions to generate Figure 7. As the figure shows, for those who endorsed 
childhood factors in the etiology of depression more strongly, a larger effect of combination 
treatment as compared with the control condition was observed. For those who did not endorse 
childhood etiological factors, the combination treatment resulted in views of the credibility of 
combined treatment that were more similar to the control condition.  
Other Exploratory Analyses: Effects of Personalization and Preference as a Moderator 
Personalization 
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 Analysis of the effect of condition by personalization on the seven outcome variables 
found no significant results (ps > .05). 
Preference 
Analysis of preference as a potential moderator on the effect of condition on the seven 
outcome variables failed to identify any significant moderating effects (ps > .05).  
Discussion 
 In this study, I examined the impact of information about CBT, ADM, and combination 
treatments on credibility, expectations, and prognostic pessimism. I hypothesized that 
participants who received a video about a type of treatment option would report higher 
credibility and expectations of that treatment option than control. The results of this study were 
partially consistent with that hypothesis. Compared to the control condition, videos describing 
either single treatment alone (CBT and ADM conditions) enhanced expectations and credibility 
for that condition relative to the control condition, with the exception of expectations of ADM. 
Instead, the only significant difference between groups for expectations of ADM was that 
participants in the ADM condition reported enhanced expectations compared to the CBT group. 
These findings show a clear relationship between providing information on a treatment option 
and the credibility and expectations of that treatment option, and this knowledge is important to 
consider when providing messages about treatment options.  
The credibility and expectations of combination treatment did not differ from control for 
those who viewed the combined treatment option. I want to emphasize that I failed to condition 
differences for the combination treatment condition in any of the dependent variables in this 
study, with the exception of the CBT condition reporting significantly higher expectations of 
CBT compared to the combination treatment condition. However, this lack of differences may 
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potentially be explained by differences in the persuasiveness of the combination video compared 
to the other single treatment videos. It is clear that the ADM and CBT videos were persuasive 
enough to produce a significant effect, but perhaps the result is less persuasive when information 
from both rationales are provided together.  
Another reason why this may be the case is that participants’ views of combination 
therapy may be more complicated than their view of CBT or ADM alone. The mean values of 
the dependent variables for combination treatment and ADM conditions were almost always 
more similar to one another than to the CBT group. One explanation for this could be that people 
associate combination treatment more closely with ADM than with CBT, or perhaps the presence 
of medication in combination therapy has more of an effect on their expectations and credibility 
than the presence of therapy. Participants who preferred ADM initially were relatively 
uncommon, and a close association with ADM and combination treatment may have been driven 
by those who viewed ADM less favorably also holding similar views about combination 
treatment. Despite the nonsignificant findings, these responses do provide some insight into 
participants’ views of combination treatment, and which is useful for informing future studies.  
Contrary to my hypothesis, prognostic pessimism did not differ across groups, 
personalization was not found to have a significant impact on the primary dependent variables, 
and I failed to find any evidence of preference as a moderator of the impact of condition on the 
dependent variables. While it is important to recognize that I failed to find any evidence for the 
effect of condition on prognostic pessimism, I suggest that some of the nonsignificant findings 
may be a result of the limitations of this study, which I will expand on in the limitations section. 
 Before beginning discussion of the potential moderators of condition differences, it is 
important to state how the large number of tests suggest any findings must be interpreted with 
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caution. Despite being exploratory analyses, they provide important insight into the impact of 
treatment information messaging and the dependent variables of credibility and expectations. 
Analysis of the moderation effect of stigma found that the superiority of the ADM condition over 
control for the credibility and expectations of ADM was strongest for participants who reported 
low personal stigma. I predicted that personal stigma would moderate credibility and 
expectations of CBT in a way that high personal stigma would strengthen the superiority of the 
CBT condition over control, my rationale being that those who support CBT believe their 
depression to be more characterological than a biological illness, and that this would be 
associated with higher personal stigma. While there was no evidence to support this prediction, I 
did find that the superiority of the ADM condition over control for credibility and expectations 
of ADM was strongest for participants with low personal stigma. This may be due to a similar 
phenomenon in which participants who see depression as being less stigmatized are more readily 
willing to accept ADM and the accompanying rationale that emphasizes biological factors.  
In the exploration of beliefs about the etiology of depression moderation effect, I found 
that for the credibility of combination therapy, the superiority of the combination therapy 
condition over control was strongest for participants who reported enhanced childhood beliefs 
about the etiology of depression. This may be due to participants believing that a depression with 
its causes situated in childhood is likely to require a treatment that involves targeting both 
psychological and biological factors. It is interesting that this effect was obtained for credibility 
but did not extend to expectations of combination treatment. I did not predict this specific 
moderation effect, but it is relevant for informing the direction of future studies in addition to the 
other results pertaining to combination treatment.  
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Overall, this study has shown that there are some clear effects of treatment information 
messaging on people’s expectations and views of the credibility of those treatment options. In 
addition, responses to message about combination treatment appeared to be more similar to 
messages about ADM alone than messages about CBT alone. These findings tell us that the type 
of information that is provided to potential patients does have an effect on credibility and 
expectations, which may inform potential strategies for discussing treatment information with 
potential patients. The implications of this for future research are discussed in the future research 
section below.  
Limitations 
 A key limitation of the study is that presentation of the treatment option messaging relied 
on brief videos (2 minutes). It is possible that longer or more interactive messages would have a 
greater impact. This may be particularly true for the information about combination treatment, as 
coverage of each treatment was even more limited. Similarly, it is possible that a 2-minute video 
may not be long enough to significantly reduce prognostic pessimism. This limitation of a short 
video length also applies to the emphasis on personalization. Perhaps a longer portion dedicated 
to personalization would have provided a more impactful message.  
 Another limitation arises from the study design. Participants were randomly assigned to 
seven conditions, a CBT condition, ADM condition, combination treatment condition, all with 
and without an emphasis on personalization, and a final control condition. While personalization 
did not appear to have an effect on the dependent variables, it is important to recognize this as a 
difference in experimental manipulation within conditions when discussing the primary 
outcomes. Additionally, there may be a lack of power to assess the moderation effects of 
preference on the outcome variables. This is due to the fact that the vast majority of participants 
IMPACT OF TREATMENT INFORMATION 
 
27 
preferred CBT, and as a result most participants did not receive a video that matched with their 
preference.  
 The final limitation of this study is that a large number of tests were examined as part of 
the data analysis. For the primary outcomes, I assessed participants’ expectations and views of 
the credibility of all three treatment options, to address the research question of how receiving 
information about one treatment option affected participants’ views of all treatment options. As 
stated previously, Tukey’s HSD was used to address the issue of Type I error, although this does 
not correct for the total number of tests used across the models examined. The caution needed in 
interpreting findings given the number of tests is all the more relevant to the exploratory 
analyses, which included a large number of tests.  
Future Directions 
 Future studies should directly address the limitations of this study. Replication of the 
findings of this study would bolster confidence in the results. In future research, investigators 
might consider testing longer, more intensive messages. It would also be useful to generate 
messages that are designed to be as similar as possible to the messages patients would be likely 
receive in interacting with their primary care physicians. It is also important to consider a design 
which takes into account that preference for treatment will not be evenly distributed across the 
sample, to ensure that tests of the effects of preference will be powered adequately.  
 In addition to addressing the limitations of the study, future studies should expand on 
these findings to assess how different types of informational videos may affect the study 
variables. For example, future research could determine how variables such as the expertise of 
the narrator, the level of research-based information provided in the video, comparing the 
benefits of treatment options, or the use of actual marketing and other types of messages. These 
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changes could be used to examine the effect of practical, real-life examples of treatment 
information, which is important for informing how these messages impact potential patients 
directly.  
Another goal of future research should be to examine how treatment information affects 
treatment seeking, adherence and outcomes. This study used credibility and expectations as 
dependent variables due to their established important in predicting treatment outcome. 
Assessing them directly will be incredibly valuable for addressing the issues of low treatment 
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Sex  Frequency Percent 
Male 116 38.67% 
Female 174 58.00% 
Prefer not to answer 10 3.30% 
   
Gender Frequency Percent 
Male  114 38.00% 
Female 173 57.67% 
Nonbinary 3 1.00% 
Prefer not to answer 10 3.30% 
   
Race/Ethnicity Frequency Percent 
White 234 78.00% 
Black 29 9.67% 
Asian  22 7.33% 
Hispanic/Latino 4 1.33% 
Arab 1 0.33% 
Mixed 5 1.67% 
Native Hawaiian or Pacific Islander 1 0.33% 
Prefer not to answer 4 1.33% 
   
Income Frequency Percent 
Less than $30,000 67 22.33% 
$30,000 to $44,999 48 16.00% 
$45,000 to $59,999 59 19.67% 
$60,000 to $74,999 39 13.00% 
$75,000 to $89,999 24 8.00% 
$90,000 to $104,999 22 7.33% 
$105,000 to $119,999 10 3.33% 
Over $120,000 25 8.33% 




Note. Gender, racial, and ethnic categories represent self-identifications chosen by participants 















































Preference  Frequency Percent 
CBT  143 47.67% 
ADM  46 15.33% 
Combo  111 37.00% 
    
Match/Mismatch  Frequency  Percent 
Mismatch  228 76.00% 
Match   72 24.00% 








Control (N=75) 41 9 25 
CBT Video (N=75) 35 10 30 
ADM Video (N=75) 35 12 28 
Combination Video (N=75) 32 15 28 
Note. Match refers to participants receiving a video about the treatment 
option they preferred. The details section shows what combinations of 
preference and condition were present.   
Table 2 
 
Preference and Match/Mismatch 



















Control - CBT -0.55 
Control - ADM -0.08 
Control - Combo -0.17 
CBT - ADM 0.47 
CBT - Combo 0.38 

























Panel A  
 
Credibility of CBT by Condition 
 
 
Note. Means have been adjusted for the level of the variable prior to the 
manipulation. Error bars shown represent standard error. Bars that 





Credibility of CBT by Condition Effect Sizes (Hedges’ g) 
 
 
Note. Small effect = 0.2. Medium 
effect = 0.5. Large effect = 0.8. 











Control - CBT -0.64 
Control - ADM -0.14 
Control - Combo -0.25 
CBT - ADM 0.50 
CBT - Combo 0.39 




























Panel A  
 
Expectations of CBT by Condition 
 
 
Note. Means have been adjusted for the level of the variable prior to the 
manipulation. Error bars shown represent standard error. Bars that 





Expectations of CBT by Condition Effect Sizes (Hedges’ g) 
 
 
Note. Small effect = 0.2. Medium 
effect = 0.5. Large effect = 0.8. 







Control - CBT 0.06 
Control - ADM -0.54 
Control - Combo -0.34 
CBT - ADM -0.59 
CBT - Combo -0.39 
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Figure 3 
 
Panel A  
 
Credibility of ADM by Condition 
 
 
Note. Means have been adjusted for the level of the variable prior to the 
manipulation. Error bars shown represent standard error. Bars that 





Credibility of ADM by Condition Effect Sizes (Hedges’ g) 
 
 
Note. Small effect = 0.2. Medium 
effect = 0.5. Large effect = 0.8. 







Control - CBT 0.18 
Control - ADM -0.38 
Control - Combo -0.05 
CBT - ADM -0.56 
CBT - Combo -0.23 

























AB A B AB
Figure 4 
 
Panel A  
 
Expectations of ADM by Condition 
 
 
Note. Means have been adjusted for the level of the variable prior to the 
manipulation. Error bars shown represent standard error. Bars that 





Expectations of ADM by Condition Effect Sizes (Hedges’ g) 
 
 
Note. Small effect = 0.2. Medium 
effect = 0.5. Large effect = 0.8. 
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Figure 5 
 
Personal Stigma as a Moderator of the Effect of Condition (viz. ADM vs. 
Control) in Predicting Credibility of ADM 
 
C 
Note. Model predicted values for credibility of ADM are shown for 
those in the ADM and control groups and those with a personal stigma 
score 1 SD above and 1 SD below the mean 
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Figure 6 
 
Personal Stigma as a Moderator of the Effect of Condition (viz. ADM vs. 
Control) in Predicting Expectations of ADM 
 
C 
Note. Model predicted values for expectations of ADM are shown for 
those in the ADM and control groups and those with a personal stigma 
score 1 SD above and 1 SD below the mean 















































Childhood Rationales for Depression as a Moderator of the Effect of Condition (viz. 
Combination Treatment vs. Control) in Predicting Credibility of Combination Treatment 
 
C 
Note. Model predicted values for credibility of combination treatment are 
shown for those in the combination treatment and control groups and those 
with a childhood rationales for depression score 1 SD above and 1 SD below 
the mean 
